Delivery Order W81K0023D0003-W81K0026FA056

The Defense Health Agency issued a delivery order to Roche Diagnostics Corporation on April 8, 2025, with a ceiling value of $726,339.69 for automated core lab services and the addition of new contract line items and fiscal year 2025 funding. Place of performance is Castleton, Indiana. The order is firm fixed price with an ultimate completion date of September 30, 2025. No set-aside was used. The delivery order is issued under a parent indefinite delivery contract with the Defense Health...

The Defense Health Agency awarded a $147,897.25 firm fixed-price delivery order to Roche Diagnostics Corporation for consumables delivery, with a completion date of January 30, 2026. The delivery order, which represents a child contract with no set-aside designation, will be performed in Castleton, Indiana. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, specializes in in vitro diagnostic solutions, laboratory instruments, and reagents for clinical...

The Defense Health Agency issued a delivery order to Roche Diagnostics Corporation on October 1, 2025, for Roche Ventana Medical System platforms (reagents and instruments) for the Department of Pathology, with a ceiling value of $354,964.92 under firm fixed-price terms. Place of performance is Castleton, IN. The order is due for ultimate completion on September 30, 2026. The delivery order was issued without a set-aside designation, procuring diagnostic reagents and consumables for histology...

The Defense Health Agency awarded a delivery order valued at $482,006 to Roche Diagnostics Corporation for chemistry and immunoassay laboratory testing services on a cost-per-reportable-result basis. This non-set-aside contract, effective May 1, 2022, through April 1, 2023, will be performed at Roche's facility in Castleton, Indiana. The award utilizes firm fixed-price pricing under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration schedule, enabling the federal...

The Defense Health Agency awarded a $31,230 delivery order to Roche Diagnostics Corporation for customized reagents and consumables on September 2, 2025. This firm fixed price contract, which serves as a child order under a larger contract vehicle, will be performed in Castleton, Indiana. The award carries no set-aside designation, reflecting open competition in the federal marketplace. Roche Diagnostics Corporation, a foreign-owned manufacturer specializing in in vitro diagnostics and...

<p>The Defense Health Agency issued a delivery order to Roche Diagnostics Corporation on May 15, 2026, for cost-per-reportable-result reagents, controls, and consumables for clinical chemistry and immunoassay testing, with a ceiling value of $2,146,420.88 under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III).</p> <p>Place of performance is Castleton, Indiana. The order is firm fixed price and runs through September 30, 2027. No set-aside was used.</p>

The Defense Health Agency (DHA) awarded a delivery order valued at $463,109.60 to Roche Diagnostics Corporation for the purchase of consumable laboratory test and quantification materials. The contract, effective as of August 1, 2025, with an ultimate completion date of September 23, 2025, is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Performance will take place in Silver Spring, Maryland. This delivery order represents a child contract under...

Roche Diagnostics Corporation received a $24,945.59 firm fixed-price blanket purchase agreement (BPA) call order from the Defense Health Agency on January 25, 2026, for clinical analyzers serving a medical treatment facility laboratory in Castleton, Indiana. This contract represents a child order under a larger indefinite delivery vehicle and carries no set-aside designation, reflecting open competitive procurement. The award is scheduled for completion by September 30, 2026, and will provide...

Roche Diagnostics Corporation received a $3.62 million delivery order from the Defense Health Agency on December 1, 2022, for clinical chemistry and immunoassay analyzers with performance extending through September 30, 2027. This firm fixed-price contract, awarded without set-aside designation, represents a child order under the GSA Schedule Critical Analyzers, Laboratory (FSS-66-III) and leverages Roche's established relationship with the Defense Health Agency for diagnostic laboratory...

The Defense Health Agency has awarded a delivery order valued at $2.19M to Roche Diagnostics Corporation for core laboratory chemistry testing services through September 30, 2025. This firm fixed-price delivery order, which was awarded on October 1, 2024, will be performed at Fort Sam Houston in San Antonio, Texas, supporting the military healthcare system's diagnostic testing capabilities. The award carries no set-aside designation, indicating it was competed openly in the federal...